Cargando…
Acute Myeloid Leukemia: Is It T Time?
SIMPLE SUMMARY: Acute myeloid leukemia (AML) is a cancer characterized by impaired differentiation and excessive expansion of blood progenitor cells leading to their accumulation in the bone marrow and circulation. The aim of this review is to describe how these leukemic cells can influence the immu...
Autores principales: | Khoud, Meriem Ben, Ingegnere, Tiziano, Quesnel, Bruno, Mitra, Suman, Brinster, Carine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156992/ https://www.ncbi.nlm.nih.gov/pubmed/34069204 http://dx.doi.org/10.3390/cancers13102385 |
Ejemplares similares
-
Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity
por: Mopin, Alexia, et al.
Publicado: (2022) -
Put in a “Ca(2+)ll” to Acute Myeloid Leukemia
por: Lewuillon, Clara, et al.
Publicado: (2022) -
B7‐H3 protein expression in acute myeloid leukemia
por: Guery, Thomas, et al.
Publicado: (2015) -
Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone size
por: Berthon, Celine, et al.
Publicado: (2020) -
Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia
por: Boyer, Thomas, et al.
Publicado: (2016)